Gut health hope: probiotic trial targets Alzheimer's risk
NCT ID NCT07413744
First seen Feb 21, 2026 · Last updated May 20, 2026 · Updated 10 times
Summary
This study looks at whether taking a daily probiotic pill is safe and practical for people with early Alzheimer's or those at risk. Researchers will enroll 40 adults aged 60 and older and follow them for up to one year. The main goal is to check for side effects and see if people can stick with the supplement, not to treat the disease itself.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Wisconsin Hospitals and Clinics
Madison, Wisconsin, 53792, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.